Heres what you need to know: Reasons to Switch Youre experiencing side effects with the current medication Insurance coverage changes Different effectiveness levels Cost considerations The Switching Process Gradual transition with medical oversight May require a washout period Dose adjustments needed Monitor for effectiveness and side effects Never switch medications on your own
Whats the plan to protect my muscles
Ive observed that there are 5 obstacles patients experience with these medications as treatments for obesity and diabetes: Cost of the meds Side effects and tolerability Fear of needles Concerns about safety The moral failing of needing a medication Oral GLP1 drugs like orforglipron (Foundayo) and Wegovy work almost as well as the injectable version of these drugs The FDA just approved oral Foundayo for the treatment of obesity based on the results of the ATTAIN-1 trial, recently published in NEJM
treated streptozotocin-induced DM rats with exenatide, a GLP-1R agonist, for 8 weeks and found that exenatide treatment attenuated the reduction in motor nerve conduction velocity and paw intraepidermal fibre density (50)
Risk factors that matter most Not everyone on semaglutide faces the same blood clot risk
Counterfeit Ozempic-style drugs slip into supply chains as scammers target weight-loss demand Counterfeit GLP1 drugs are now turning up at Canadian retailers and on popular websitesputting plan members at risk of taking products that may contain the wrong dose, dangerous contaminants or no active drug at all
